Together we’re unlocking the true potential of clinical trial lab data, bringing faster insights, smarter decisions, and better outcomes. JOHNSON CITY, Tenn. and HOUSTON, Sept. 15, 2025 /PRNewswire/ — LabConnect, a leading global provider of… Read More »LabConnect and OmniScience to Deliver First Agentic AI Solution for Real-Time Clinical Trial Lab Insights
NEW YORK, Sept. 15, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading… Read More »NYSE Content Advisory: Pre-Market Update + S&P comes off best week since August
Megan Pennington Integrative Health announces holistic therapy for dermatological conditions, including psoriasis and dermatitis, focusing on inflammation reduction and addressing root causes rather than symptoms. Champlain, United States, September 15, 2025 — Megan Pennington Integrative… Read More »Pleasanton, CA, Customized Holistic Therapy for Psoriasis & Dermatitis Announced
Polymarket becomes Official Prediction Markets Partner for Stocktwits NEW YORK, NY, September 15, 2025 — Polymarket, the world’s largest prediction market platform, and Stocktwits, the largest social platform for investors and traders, today announced a… Read More »Stocktwits and Polymarket Join Forces: The World’s Largest Prediction Market and the World’s Largest Social Platform for Finance Launch New Earnings Markets
Nightly’s first record deal signing is DNA, the official DJ duo based out of Dallas, Texas. Dallas, Texas, United States, September 15, 2025 — Nightly has officially launched Nightly Records, a new music division built… Read More »Nightly Records Launches with First Signing: DNA, the Official DJ Behind the Movement
STEMart announces the launch of its Bacterial Reverse Mutation Test (Ames) service. New York, United States, September 15, 2025 — STEMart, a US-based provider of comprehensive services for all phases of medical device development, announced… Read More »STEMart Launches Advanced Bacterial Reverse Mutation Test (Ames) Service to Accelerate Medical Device Safety Assessment